OPTA:: Optimal treatment of anaemia in patients with chronic kidney disease (CKD)

被引:3
|
作者
Hoerl, W. H.
Vanrenterghem, Y.
Aljama, P.
Brunet, P.
Brunkhorst, R.
Gesualdo, L.
Macdougall, I.
Wanner, C.
Wikstroem, B.
机构
关键词
D O I
10.1093/ndt/gfm017
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:III20 / III26
页数:7
相关论文
共 50 条
  • [1] ANAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) IN RENAL PRACTICES: A REPORT FROM CKD.QLD
    Healy, H. G.
    Wang, Z.
    Huynh, S.
    Kirby, J.
    Salisbury, A.
    Hoy, W. E.
    NEPHROLOGY, 2014, 19 : 71 - 71
  • [2] SYMPTOMS AND IMPACTS ASSOCIATED WITH ANAEMIA OF CHRONIC KIDNEY DISEASE (CKD)
    Wiklund, I
    Eriksson, D.
    Cooper, O.
    van Nooten, F.
    Holmstrom, S.
    VALUE IN HEALTH, 2012, 15 (07) : A516 - A516
  • [3] Treatment patterns of anemia in patients with chronic kidney disease (CKD).
    Rao, M
    Pereira, B
    Scarlata, D
    Brenner, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 816A - 816A
  • [4] Roxadustat in the treatment of anaemia in chronic kidney disease
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (01) : 125 - 133
  • [5] Awareness of chronic kidney disease (CKD) among CKD patients
    Alghamdi, Abdullah H.
    Alshehri, Abdulrahman S.
    Alaseri, Ahmed Z.
    Alqarni, Khalid S.
    Almutairi, Salman K.
    Alaryni, Abdullah A.
    Alshammari, Omar A.
    Alenazi, Hanadi H.
    Alenazi, Nshmiah S.
    Qutub, Rayan
    Alammari, Yousef
    Al-Harbi, Khalid
    Hakami, Osamah A.
    Bukhari, Abdullah
    MEDICAL SCIENCE, 2022, 26 (124)
  • [6] OPTA - OPTIMAL TREATMENT OF RENAL ANAEMIA: IRON AS A MAJOR FACTOR INFLUENCING TREATMENT OUTCOME
    Schaefer, Roland M.
    Macdougall, Iain C.
    Rossert, Jerome
    Hoerl, Walter H.
    NEPHROLOGY, 2005, 10 : A311 - A311
  • [7] OPTA - Optimal treatment of renal anaemia: Iron as a major factor influencing treatment outcome
    Schaefer, RM
    Macdougall, IC
    Rossert, J
    Hoerl, WH
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V275 - V275
  • [8] Causal Factors of Anaemia in Kidney Transplant (KT) Patients with Stage 3-4 Chronic Kidney Disease (CKD).
    Gentil, Miguel A.
    Cabello, V.
    Campistol, J. M.
    Gomez, C.
    Polo, J.
    Ortega, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 247 - 248
  • [9] Optimal Treatment of Renal Anaemia (OPTA):: improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin
    Hörl, WH
    Vanrenterghem, Y
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : III25 - III32
  • [10] PROGRESSION OF KIDNEY DISEASE IN A COHORT OF CHRONIC KIDNEY DISEASE (CKD) PATIENTS
    Wang, Z.
    Zhang, J.
    Adegbija, O.
    Abeysekera, R.
    Healy, H. G.
    Tan, K. S.
    Cameron, A.
    Hoy, W. E.
    NEPHROLOGY, 2017, 22 : 20 - 20